Prescription Required
Adfrar 40mg Injection 0.8ml is a powerful medication containing Adalimumab (40mg/0.8ml), an anti-inflammatory biologic used to treat various autoimmune and inflammatory diseases. It is commonly prescribed for conditions such as rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and plaques psoriasis. By targeting and inhibiting specific proteins in the immune system, Adfrar works to reduce inflammation, pain, and swelling associated with these conditions, providing significant relief and improving the quality of life for those suffering from chronic inflammatory diseases.
Avoid consuming alcohol while using Adfrar. Alcohol can interfere with the medication’s effectiveness and increase the likelihood of certain side effects, such as liver issues, gastrointestinal discomfort, or increased immune suppression.
Adfrar should be used during pregnancy only if clearly needed. Although the effects on pregnancy are not fully known, the medication can affect the immune system, potentially impacting the fetus. Consult your healthcare provider before starting Adfrar if you are pregnant or planning to become pregnant.
Adalimumab, the active ingredient in Adfrar, is known to pass into breast milk in small amounts. It is generally considered safe to use while breastfeeding, but it is essential to discuss this with your doctor to weigh the potential risks and benefits.
Adfrar is unlikely to affect your ability to drive or operate machinery. However, if you experience side effects such as dizziness, fatigue, or other symptoms, avoid driving or performing tasks that require full concentration.
Adfrar should be used with caution if you have kidney problems. Patients with impaired kidney function may require dosage adjustments or closer monitoring. Always inform your doctor about any pre-existing kidney conditions.
Adfrar may cause liver problems in some individuals, so regular monitoring of liver function tests is recommended. Inform your healthcare provider if you have a history of liver disease before starting treatment with Adfrar.
Adfrar 40mg Injection 0.8ml contains Adalimumab, a monoclonal antibody that works by targeting and blocking a substance in the body called tumor necrosis factor-alpha (TNF-alpha). TNF-alpha plays a key role in inflammatory processes, and excessive levels can lead to chronic inflammation, pain, and tissue damage in conditions like rheumatoid arthritis and psoriasis. By inhibiting TNF-alpha, Adalimumab helps reduce inflammation and improves symptoms associated with autoimmune diseases.
Rheumatoid Arthritis is a chronic autoimmune disease that causes joint inflammation, resulting in pain, stiffness, and potential joint damage. Psoriatic Arthritis is a form of arthritis linked to psoriasis, characterized by joint pain, swelling, and skin changes. Crohn’s Disease is an inflammatory bowel disease that leads to gastrointestinal tract inflammation, causing symptoms like abdominal pain, diarrhea, and weight loss. Ulcerative Colitis is a chronic condition affecting the colon and rectum, leading to inflammation, ulcers, diarrhea, abdominal pain, and bleeding. Ankylosing Spondylitis primarily affects the spine, causing pain and stiffness, often leading to reduced mobility.
Store Adfrar 40mg Injection in the refrigerator, away from direct sunlight and moisture. Do not freeze the medication. Ensure it is kept out of reach of children.
Adfrar 40mg Injection 0.8ml is an effective biologic treatment for inflammatory conditions like rheumatoid arthritis, Crohn’s disease, and psoriasis. By inhibiting TNF-alpha, it helps reduce inflammation, manage symptoms, and improve quality of life. Always follow your healthcare provider's advice for the best results and monitor your health regularly during treatment.
Content Updated on
Wednesday, 5 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA